The market for CBD expanded itself in a way that has not been seen with other products. This cannabinoid comes in various forms to the market, from jellybeans and edible candies to even dog treats. Cannabidiol is among the dozens of cannabinoids made by plants in the Cannabis sativa genus. CBD recently became the best-known cannabinoid, a title that once belonged to tetrahydrocannabinol (THC). However, not all Cannabis sativa plants have a lot of THC: the ones that have are regarded as marijuana, whereas those which do not are referred to as hemp.
The Food and Drug Administration has not yet approved use of cannabidiol in beverages, dietary supplements or food. This means, it is not legal for manufacturers to claim that any CBD or CBD-based product has therapeutic or medical benefits. Beyond these uses, cannabidiol is not regulated at a federal level, so there can be unorganized claims for items available to commoners. Last September, the FTC notified some companies that sell CBD oils, CBD gummies and capsules that it was not legal to make such claims with no reliable and competent evidence.
In spite of the apparent lack of evidence, some individuals turn to cannabidiol as a means to treat symptoms such as pain and anxiety occasionally as a substitute for opioids. Last year, some big-name drugstores started to sell CBD products, plus celebrities started to announce product endorsements.
The Washington University Pain Center’s head of clinical research, namely Simon Haroutounian said, “CB is perceived as safe and attractive and is gaining widespread use.” According to Haroutounian, the market for CBD is booming, but the research on the substance’s potential is spotty.
Researchers are yet to figure out how the human body gets rid of cannabidiol after intake. Cannabidiol may break down in our liver, said Haroutounian, but researchers would not know how it interacts with drugs until they discover which enzymes in the body are involved.
It is also not clear how much cannabidiol goes into the blood once the user inhales CBD or takes it orally, plus if enough reaches their target tissues. Researchers still lack reliable information regarding how often should you administer cannabidiol and in what quantities.
“We are not in a very good position to make claims,” said Haroutounian. “We don’t even know what to tell people about driving impairment, whether they should avoid driving after ingesting a particular amount of CBD.”